Foley Edward D, Diaz Ricardo, Castresana Manuel R
Division of Cardiothoracic Anesthesiology and Critical Care Medicine, Department of Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
SAGE Open Med Case Rep. 2017 Dec 14;5:2050313X17741013. doi: 10.1177/2050313X17741013. eCollection 2017.
Severe sepsis has been known to trigger for takotsubo syndrome which is associated with profound physical or emotional stress. Severe sepsis is also associated with sepsis-induced cardiomyopathy, a reversible myocardial depression. We report a case in which a patient with takotsubo syndrome, cardiogenic shock, severe sepsis, and adult respiratory distress syndrome was managed with an Impella Cardiac Power circulatory support device for 108 h (4.5 days) because of sustained hemodynamic compromise. To the best of our knowledge, this represents the longest reported use of the Impella Cardiac Power device for the management of cardiogenic shock in a patient with takotsubo syndrome and severe sepsis. This report also highlights the importance of considering a ventricular assist device in the management of takotsubo syndrome cardiogenic shock with severe sepsis which is unresponsive to maximal medical therapy.
已知严重脓毒症可引发应激性心肌病,该疾病与严重的身体或情绪应激有关。严重脓毒症还与脓毒症诱导的心肌病相关,这是一种可逆性心肌抑制。我们报告了一例应激性心肌病、心源性休克、严重脓毒症和成人呼吸窘迫综合征患者,由于持续的血流动力学不稳定,使用Impella心脏动力循环支持装置治疗108小时(4.5天)。据我们所知,这是Impella心脏动力装置用于治疗应激性心肌病和严重脓毒症患者心源性休克的最长报道使用时间。本报告还强调了在治疗对最大程度药物治疗无反应的应激性心肌病心源性休克合并严重脓毒症时,考虑使用心室辅助装置的重要性。